Sculptra Chart Review

N/ACompletedNCT05463978

Galderma R&D498 enrolled

Overview

Multi-center retrospective chart review to evaluate the safety of Sculptra Aesthetic when used in non-facial areas

Study Type

OBSERVATIONAL

Enrollment

498

Conditions

Non-facial Skin Aesthetic Conditions

Interventions

Sculptra AestheticDEVICE

Sculptra Aesthetic in non-facial areas

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Participants who have been treated at the site with Sculptra Aesthetic in non-facial areas * Participants with available information about treatment dates and treatment procedures Exclusion Criteria: * Participant that have actively asked not to be involved in a study or registry * Other conditions that in the Investigator's opinion would exclude the participant from participation ; the condition should be recorded.

Locations (8)

Galderma Research Site

Pasadena, California, United States

Galderma Research Site

San Diego, California, United States

Galderma Research Site

Solana Beach, California, United States

Galderma Research Site

Coral Gables, Florida, United States

Outcomes

Primary Outcomes

Number of Participants With Adverse Events (AEs) Related to the Sculptra Aesthetic Reported in the Medical Chart

Related AE was defined as a reasonable possibility that Sculptra Aesthetic or the injection procedure might have caused the event. AEs related to Sculptra Aesthetic or the injection procedure in non-facial areas were identified by review of the medical charts of between January 2018 to December 2020 and reported in this outcome measure.

Time frame: Retrospective data was retrieved and observed during the period from January 2018 to 24 September 2022 (up to 1728 days)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.